How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | SURGSurgePays, Inc. | GOGOGogo Inc. | SPOKSpok Holdings, Inc | OMCCOLD MARKET CAPITAL Corp | Median of the restexcluding SURG |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $0.1258▲ 0.01 (4.83%) | $2.11▲ 0.03 (1.44%) | $10.36▼ 0.19 (1.80%) | $3.90▲ 0.00 (0.00%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 4.0/10 | 6.0/10 | 8.7/10 | 4.0/10 | 6.0/10 |
| Market value | $2.7M | $283.8M | $213.5M | $26.1M | |
| Revenue | $57.0M | $910.5M | $139.7M | $9.4M | |
| Profit | -$36.1M | $12.9M | $15.9M | -$5.1M | |
| Revenue growthChange in sales versus the prior year. | -6.4% | 104.7% | 1.5% | — | 53.1% |
| Gross marginShare of sales left after the direct cost of producing them. | -18.6% | — | 78.7% | — | 78.7% |
| Operating marginShare of sales left after running the business, before interest and tax. | -59.9% | 12.5% | 14.1% | -74.3% | 12.5% |
| Profit marginProfit kept from each dollar of sales. | -63.3% | 1.4% | 11.4% | -55.0% | 1.4% |
| Free cash flow marginCash left after capital spending, as a share of sales. | -37.4% | 7.2% | 18.0% | -110.1% | 7.2% |
| Return on equityProfit against the owners' stake in the company. | 235.0% | 12.8% | 10.8% | -9.7% | 10.8% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | -241.6% | 11.1% | 12.1% | -18.7% | 11.1% |
| P/E ratioPrice paid per dollar of annual profit. | — | 21.96x | 13.45x | — | 17.70x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | 5.70x | — | — | 5.70x |
| Price to book | -0.17x | 2.81x | 1.46x | 0.49x | 1.46x |
| Debt to equityTotal liabilities compared with owners' stake. | -1.56x | 11.89x | 0.41x | 0.20x | 0.41x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 4/9 | 5/8 | 6/8 | 4/8 | 5.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | distress | safe | n/a for banks |
How SURG compares with the others
- SURG's operating margin of -59.9% is lower than the median of the other companies selected (12.5%).
- Its revenue grew more slowly than the median of the other companies selected: -6.4% against 53.1%.
- It has no P/E to set against theirs, because it did not make a profit.
- Its liabilities are lower relative to equity than the median of the other companies selected: -1.6x against 0.4x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.